Treatment of Menstrual Cycle Alterations in Adolescents
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age14-19
SponsorLo.Li.Pharma s.r.l
About this trial
the aim of the present study is intended to evaluate how treatment with Myo-Inositol and Dioscorea Villosa can help improve menstrual cycle irregularities in adolescents, both with and without PCOS.
Eligibility criteria
Qualifiers
adolescent women aged 14-19 years old, with at least 3 years passed after menarche, and oligomenorrhea or amenorrhea
Disqualifiers
Primary amenorrhea.
Hyperandrogenism due to other factors (i.e. adrenal hyperplasia or Cushing syndrome).
Hyperprolactinemia or overt hypothyroidism (TSH ≥4).
Other hormonal alterations.
Trial design
Treatments tested in this trial
- myo-Inositol plus DIoscorea Villosa
Treatment groups
20 Participants
are divided into 2 treatment groupsLocations
3Georgia
Zhordania and Khomasuridze Institute of Reproductology0112, TbilisiGeorgia, Georgia
Italy
Agunco00155, RomeItaly, Italy
Russia
Department of Obstetrics and Gynecology with Reproductive Medicine, F.I. Inozemtsev Academy of Medical Education Saint PetersburgRussian Federation, Russia
Sponsors and collaborators
Lo.Li.Pharma s.r.l
Lead sponsor
AGUNCO Obstetrics and Gynecology Centre
Sponsor institution
Source ClinicalTrials.gov